Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated
Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated
Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
11 Jun 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_FWN42J00X:0-cipla-says-usfda-classified-verna-manufacturing-facility-inspection-as-voluntary-action-indicated/